Nanoligent closes €12 million Series A financing to advance its lead oncology nanodrug
Nanoligent is proud to announce the completion of a €12 million Series A financing round led by Inveready (Inveready Biotech IV), with participation from CDTI (through the Innvierte program), Clave Capital (Clave Innohealth), and existing investors i&i Biotech Fund I, Italian Angels for Growth / Nanolinvest, and AVANTECA Partners. The proceeds will support completion of […]
Nanoligent wins the Santander X Award for Best UAB’s University Start-up
We are proud to announce that Nanoligent has won the Santander X Award 2025 in the category of Best University Start-up from UAB, at the awards ceremony held on June 19th at the Universitat Autònoma de Barcelona (UAB). This award, promoted by Banco Santander and Emprèn UAB, recognizes entrepreneurial projects with high social and economic […]
Call of the ordinary general shareholders meeting of the company Nanoligent, S.L.
ENGLISH The Board of Directors of Nanoligent, S.L. has convened the Ordinary General Shareholders Meeting to be held on June 11, 2025, at 10:00 a.m. The meeting will take place at the Barcelona Chamber of Commerce, Diagonal 452, 2nd floor, in Barcelona. In compliance with the Capital Companies Act, shareholders may access all documentation related […]
Nanoligent grows its scientific team with the incorporation of two Torres Quevedo Scientists
The aim of the Torres Quevedo grant is to promote the professional growth of researchers and meet the demand in the private sector for highly skilled personnel capable of leading research and development projects. Additionally, it contributes to the consolidation of recently established technology companies. Andrea Livieri, PhD and Patricia Álamo, PhD, have been […]
Nanoligent Receives Innovation Recognition from Cerdanyola Empresarial
We are thrilled to announce that Nanoligent has been selected by the Associació d’Empreses de Cerdanyola del Vallès-Cerdanyola Empresarial to receive a coveted Innovation Recognition at the upcoming 10th Cerdanyola Business Night. The award ceremony, organized by Cerdanyola Empresarial, is set to take place on November 23rd at 8 pm at the Hotel Campus of […]
Nanoligent Joins Arquímedes Accelerator for Intensive Growth Program
Nanoligent is proud to announce its active participation in the Arquídemes Accelerator, a groundbreaking initiative in collaboration with Santander Bank (Universidades section). This first edition of the program is dedicated to fostering the growth of emerging companies, mainly spin-offs from the University. Over the two months, Nanoligent, along with 13 other cutting-edge companies, will benefit […]
Nanoligent raised €2.8 M and completed Seed round financing with support of i&i Biotech Fund I
PRESS RELEASE Barcelona, Spain September 27th 2022 – Nanoligent SL, a Spanish biotech company specialized in the development of cancer treatments based on unique protein conjugates, today announces the completion of a Seed financing round of total € 2.8 M. The final closing of the Seed round consists of € 1 M investment by i&i Biotech […]
Nanoligent raises €1M in Series Seed financing
PRESS RELEASE Barcelona, Spain Barcelona, Spain – Milan, Italy – Basel, Switzerland, February 3rd, 2022 – Nanoligent SL, a biotech company specialized in the development of nanotechnology-based cancer treatments, today announces the completion of the first closing of a Seed financing round of €1M. The round has been led by members of Italian Angels for Growth, […]
6th MEET2WIN European Oncology Partnering Convention
Nanoligent has been selected for pitching next May 5th in the Oncology Upward Investment session of the 6th edition of the MEET2WIN European Oncology Partnering Convention. MEET2WIN is an European Partnering Convention fully dedicated to open innovation in oncology. For 2 days, the congress will host conferences, project pitches, one-to-one business meetings and an exhibition area. […]
28th Healthcare Investment Forum, 24th March 2021
Nanoligent has been selected to showcase at the 28th Healthcare Investment Forum the next 24th of March. The Healthcare Barcelona Investment Forum is a meeting point for entrepreneurs and investors in the healthcare sector. All kinds of companies can be presented with projects related to Biotechnology, Medical Devices, Health Services and Information Technologies related to health. […]
